PT Kalbe Farma Tbk
PTKFF
Market Cap$4.35B
Close$
$0.22
256.2% upside
Current Fair Value
256.2% upsideUndervalued by 256.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.35 Billion |
|---|---|
| Enterprise Value | $-2,663,605,109,297.00 |
| Dividend Yield | $0.00 (2.96%) |
| Earnings per Share | $70.22 |
| Beta | 0.01 |
| Outstanding Shares | 46,149,181,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 16.18 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | -0.1 |
| Enterprise Value to EBIT | -0.71 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | -0.43 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About PT Kalbe Farma Tbk
CEO: Vidjongtius PT Kalbe Farma Tbk engages in the development, distribution, and trading of pharmaceutical products. It operates through the following segments: Prescription Pharmaceutical, Consumer Health, Nutritionals, and Distribution and Logistic. T...